BLRX logo

BioLineRx (BLRX) Depreciation And Amortization

Annual D&A

$1.38 M
+$730.00 K+111.62%

31 December 2023

1-Year Change

+111.62%
BLRX annual depreciation & amortization is up +111.62% year-on-year

3-Year Change

+48.18%
BLRX annual depreciation & amortization is up +48.18% over the past 3 years

All-time High

$1.38 M
BLRX annual depreciation & amortization is currently at an all-time high

Sector Rank

43.73%
BLRX annual depreciation & amortization is higher than 43.73% of companies in Healthcare sector
Annual Total Expenses$47.79 M
BLRX annual total expenses is $47.79 million
Annual Operating Expenses$44.10 M
BLRX annual total operating expenses is $44.10 million
Annual Revenue$4.80 M
BLRX annual revenue is $4.80 million
Annual Net Income-$60.61 M
BLRX annual net profit is -$60.61 million

BLRX Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly D&A

$840.00 K
+$364.00 K+76.47%

30 September 2024

1-Year Change

+280.09%
BLRX quarterly depreciation & amortization is up +280.09% year-on-year

3-Year Change

+402.99%
BLRX quarterly depreciation & amortization is up +402.99% over the past 3 years

All-time High

$897.00 K
BLRX quarterly depreciation & amortization is currently -6.35% below its historical high of $897.00 thousand

Sector Rank

55.84%
BLRX quarterly depreciation & amortization is higher than 55.84% of companies in Healthcare sector
Quarterly Total Expenses$10.33 M
BLRX quarterly total expenses is $10.33 million
Quarterly Operating Expenses$9.51 M
BLRX quarterly total operating expenses is $9.51 million
Quarterly Revenue$4.94 M
BLRX quarterly revenue is $4.94 million
Quarterly Net Income-$5.82 M
BLRX quarterly net profit is -$5.82 million

BLRX Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM D&A

$2.92 M
+$619.00 K+26.91%

30 September 2024

1-Year Change

+237.46%
BLRX TTM depreciation & amortization is up +237.46% year-on-year

3-Year Change

+302.07%
BLRX TTM depreciation & amortization is up +302.07% over the past 3 years

All-time High

$2.92 M
BLRX TTM depreciation & amortization is currently at an all-time high

Sector Rank

53.41%
BLRX TTM depreciation & amortization is higher than 53.41% of companies in Healthcare sector
Annual Total Expenses$47.79 M
BLRX annual total expenses is $47.79 million
Annual Operating Expenses$44.10 M
BLRX annual total operating expenses is $44.10 million
TTM Revenue$21.99 M
BLRX TTM revenue is $21.99 million
TTM Net Income-$19.92 M
BLRX TTM net profit is -$19.92 million

BLRX TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BLRX Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+111.6%+280.1%+237.5%
3 y3 years+48.2%+403.0%+302.1%
5 y5 years+153.9%+268.4%+265.8%

BLRX Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+111.6%-6.3%+495.7%at high+355.4%
5 y5 yearsat high+153.9%-6.3%+495.7%at high+355.4%
alltimeall timeat high+414.5%-6.3%+476.0%at high

BioLineRx Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sept 2024
-
$840.00 K(+76.5%)
$2.92 M(+26.9%)
June 2024
-
$476.00 K(-46.9%)
$2.30 M(+13.7%)
Mar 2024
-
$897.00 K(+27.1%)
$2.02 M(+46.1%)
Dec 2023
$1.38 M(+111.6%)
$706.00 K(+219.5%)
$1.38 M(+60.0%)
Sept 2023
-
$221.00 K(+11.6%)
$865.00 K(+8.5%)
June 2023
-
$198.00 K(-23.6%)
$797.00 K(+7.7%)
Mar 2023
-
$259.00 K(+38.5%)
$740.00 K(+13.1%)
Dec 2022
$654.00 K(-7.0%)
$187.00 K(+22.2%)
$654.00 K(+2.0%)
Sept 2022
-
$153.00 K(+8.5%)
$641.00 K(-2.1%)
June 2022
-
$141.00 K(-18.5%)
$655.00 K(-5.6%)
Mar 2022
-
$173.00 K(-0.6%)
$694.00 K(-1.3%)
Dec 2021
$703.00 K(-24.7%)
$174.00 K(+4.2%)
$703.00 K(-3.2%)
Sept 2021
-
$167.00 K(-7.2%)
$726.00 K(-4.8%)
June 2021
-
$180.00 K(-1.1%)
$763.00 K(-4.0%)
Mar 2021
-
$182.00 K(-7.6%)
$795.00 K(-14.9%)
Dec 2020
$934.00 K(-0.6%)
$197.00 K(-3.4%)
$934.00 K(-7.5%)
Sept 2020
-
$204.00 K(-3.8%)
$1.01 M(-2.3%)
June 2020
-
$212.00 K(-34.0%)
$1.03 M(-1.3%)
Mar 2020
-
$321.00 K(+17.6%)
$1.05 M(+11.5%)
Dec 2019
$940.00 K(+72.5%)
$273.00 K(+19.7%)
$940.00 K(+17.8%)
Sept 2019
-
$228.00 K(+0.9%)
$798.00 K(+14.7%)
June 2019
-
$226.00 K(+6.1%)
$696.00 K(+12.6%)
Mar 2019
-
$213.00 K(+62.6%)
$618.00 K(+13.4%)
Dec 2018
$545.00 K(+13.3%)
$131.00 K(+4.0%)
$545.00 K(+6.0%)
Sept 2018
-
$126.00 K(-14.9%)
$514.00 K(-1.0%)
June 2018
-
$148.00 K(+5.7%)
$519.00 K(+3.4%)
Mar 2018
-
$140.00 K(+40.0%)
$502.00 K(+4.4%)
Dec 2017
$481.00 K
$100.00 K(-23.7%)
$481.00 K(-2.8%)
Sept 2017
-
$131.00 K(0.0%)
$495.00 K(+1.6%)
DateAnnualQuarterlyTTM
June 2017
-
$131.00 K(+10.1%)
$487.00 K(+1.7%)
Mar 2017
-
$119.00 K(+4.4%)
$479.00 K(-0.6%)
Dec 2016
$482.00 K(+9.3%)
$114.00 K(-7.3%)
$482.00 K(-1.0%)
Sept 2016
-
$123.00 K(0.0%)
$487.00 K(-0.8%)
June 2016
-
$123.00 K(+0.8%)
$491.00 K(+6.5%)
Mar 2016
-
$122.00 K(+2.5%)
$461.00 K(+4.5%)
Dec 2015
$441.00 K(+63.9%)
$119.00 K(-6.3%)
$441.00 K(+16.1%)
Sept 2015
-
$127.00 K(+36.6%)
$380.00 K(+16.9%)
June 2015
-
$93.00 K(-8.8%)
$325.00 K(+8.3%)
Mar 2015
-
$102.00 K(+75.9%)
$300.00 K(+11.5%)
Dec 2014
$269.00 K(-15.4%)
$58.00 K(-19.4%)
$269.00 K(-5.7%)
Sept 2014
-
$72.00 K(+5.9%)
$285.20 K(-4.5%)
June 2014
-
$68.00 K(-4.2%)
$298.60 K(-2.4%)
Mar 2014
-
$71.00 K(-4.3%)
$305.80 K(-3.8%)
Dec 2013
$318.00 K(-22.0%)
$74.20 K(-13.1%)
$318.00 K(-9.2%)
Sept 2013
-
$85.40 K(+13.6%)
$350.10 K(-2.4%)
June 2013
-
$75.20 K(-9.6%)
$358.80 K(-6.0%)
Mar 2013
-
$83.20 K(-21.7%)
$381.80 K(-6.4%)
Dec 2012
$407.90 K(-0.7%)
$106.30 K(+13.0%)
$407.90 K(+2.0%)
Sept 2012
-
$94.10 K(-4.2%)
$399.80 K(+3.2%)
June 2012
-
$98.20 K(-10.2%)
$387.40 K(-4.6%)
Mar 2012
-
$109.30 K(+11.3%)
$406.00 K(-1.1%)
Dec 2011
$410.70 K(-19.7%)
$98.20 K(+20.2%)
$410.60 K(-50.2%)
Sept 2011
-
$81.70 K(-30.1%)
$823.70 K(+58.8%)
June 2011
-
$116.80 K(+2.5%)
$518.60 K(+1.8%)
Mar 2011
-
$113.90 K(-77.7%)
$509.30 K(-0.4%)
Dec 2010
$511.30 K
$511.30 K(-328.9%)
$511.30 K(>+9900.0%)
Sept 2010
-
-$223.40 K(-307.8%)
$0.00(-100.0%)
June 2010
-
$107.50 K(-7.2%)
$223.40 K(+92.8%)
Mar 2010
-
$115.90 K
$115.90 K

FAQ

  • What is BioLineRx annual depreciation & amortization?
  • What is the all time high annual D&A for BioLineRx?
  • What is BioLineRx annual D&A year-on-year change?
  • What is BioLineRx quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for BioLineRx?
  • What is BioLineRx quarterly D&A year-on-year change?
  • What is BioLineRx TTM depreciation & amortization?
  • What is the all time high TTM D&A for BioLineRx?
  • What is BioLineRx TTM D&A year-on-year change?

What is BioLineRx annual depreciation & amortization?

The current annual D&A of BLRX is $1.38 M

What is the all time high annual D&A for BioLineRx?

BioLineRx all-time high annual depreciation & amortization is $1.38 M

What is BioLineRx annual D&A year-on-year change?

Over the past year, BLRX annual depreciation & amortization has changed by +$730.00 K (+111.62%)

What is BioLineRx quarterly depreciation & amortization?

The current quarterly D&A of BLRX is $840.00 K

What is the all time high quarterly D&A for BioLineRx?

BioLineRx all-time high quarterly depreciation & amortization is $897.00 K

What is BioLineRx quarterly D&A year-on-year change?

Over the past year, BLRX quarterly depreciation & amortization has changed by +$619.00 K (+280.09%)

What is BioLineRx TTM depreciation & amortization?

The current TTM D&A of BLRX is $2.92 M

What is the all time high TTM D&A for BioLineRx?

BioLineRx all-time high TTM depreciation & amortization is $2.92 M

What is BioLineRx TTM D&A year-on-year change?

Over the past year, BLRX TTM depreciation & amortization has changed by +$2.05 M (+237.46%)